Bulk Manufacturer of Controlled Substances Application: Synthcon LLC, 10820-10823 [2022-04057]

Download as PDF 10820 ACTION: Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices Notice of application. DEPARTMENT OF JUSTICE S&B Pharma LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on December 24, 2021, S&B Pharma LLC, 405 South Motor Avenue, Azusa, California 91702, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance lotter on DSK11XQN23PROD with NOTICES1 Gamma Hydroxybutyric Acid. Marihuana ..................... Tetrahydrocannabinols Amphetamine ............... Methamphetamine ........ Lisdexamfetamine ........ Methylphenidate ........... Pentobarbital ................ 4-Anilino-N-Phenethyl4-Piperidine (ANPP). Tapentadol .................... Fentanyl ........................ Drug code Schedule 2010 I 7360 7370 1100 1105 1205 1724 2270 8333 I I II II II II II II 9780 9801 II II The company plans to bulk manufacture the listed controlled substances for the internal use intermediates for formulation and analytical development purposes or for sale to its customers. In reference to dug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–04062 Filed 2–24–22; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 16:44 Feb 24, 2022 Jkt 256001 Controlled substance Drug code Schedule Drug Enforcement Administration [Docket No. DEA–974] Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Cedarburg Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022. ADDRESSES: DEA requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https:// www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.’’ SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on August 27, 2021, Cedarburg Pharmaceuticals, 870 Badger Circle, Grafton, Wisconsin 53024–0000, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUMMARY: Controlled substance Lysergic Acid Diethylamide. Tetrahydrocannabinols 4-Bromo-2,5Dimethoxyphenethylamine. 3,4Methylenediocyamphetamine. PO 00000 Frm 00057 Fmt 4703 Drug code Schedule 7315 I 7370 7392 I I 7400 I Sfmt 4703 3.4Methylenedioxymethamphetamine. 5-Methoxy-N-Ndimethltryptamine. Dimethyltryptamine ....... Psilocybin ..................... Psilocyn ........................ Methylphenidate ........... Nabilone ....................... 4-Anilino-N-Phenethyl4-Piperidine (ANPP). Fentanyl ........................ 7405 I 7431 I 7435 7437 7438 1724 7379 8333 I I I II II II 9801 II The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. In reference to the drug code 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture as synthetic. No other activity for this drug code is authorized for this registration. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–04064 Filed 2–24–22; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–964] Bulk Manufacturer of Controlled Substances Application: Synthcon LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Synthcon LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on December 2, 2021, SUPPLEMENTARY INFORMATION: E:\FR\FM\25FEN1.SGM 25FEN1 10821 Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices Synthcon LLC, 770 Wooten Road, Suite 101, Colorado Springs, Colorado 80915– 3538, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code 3-FMC ................................................................................................................................................................................ Cathinone .......................................................................................................................................................................... Methcathinone ................................................................................................................................................................... 4-FMC ................................................................................................................................................................................ Pentedrone ........................................................................................................................................................................ Mephedrone(4-Methyl-N-methylcathinone) ....................................................................................................................... 4-MEC ................................................................................................................................................................................ Naphyrone ......................................................................................................................................................................... N-Ethylamphetamine ......................................................................................................................................................... N,N-Dimethylamphetamine ................................................................................................................................................ Aminorex ............................................................................................................................................................................ Cis-4-Methylaminorex ........................................................................................................................................................ GHB ................................................................................................................................................................................... Methaqualone .................................................................................................................................................................... Mecloqualone .................................................................................................................................................................... JWH-250 ............................................................................................................................................................................ ADB-PINACA ..................................................................................................................................................................... JWH-018 ............................................................................................................................................................................ JWH-073 ............................................................................................................................................................................ JWH-200 ............................................................................................................................................................................ JWH-203 ............................................................................................................................................................................ 4-Methyl-alpha-ethylaminopentiophenone ......................................................................................................................... N-Ethyhexedrone ............................................................................................................................................................... AET .................................................................................................................................................................................... Ibogaine ............................................................................................................................................................................. CP-47,497 .......................................................................................................................................................................... CP-47,497 C8 HOMOLOG ................................................................................................................................................ LSD .................................................................................................................................................................................... 2C-T-7 ................................................................................................................................................................................ Tetrahydrocannabinols ...................................................................................................................................................... Mescaline ........................................................................................................................................................................... 2C-T-2 ................................................................................................................................................................................ 3,4,5-TMA .......................................................................................................................................................................... DOB ................................................................................................................................................................................... 2CB .................................................................................................................................................................................... DOM .................................................................................................................................................................................. 2,5-DMA ............................................................................................................................................................................. JWH-398 ............................................................................................................................................................................ DOE ................................................................................................................................................................................... MDA ................................................................................................................................................................................... 5-METHOXY-MDA ............................................................................................................................................................. N-HYDROXY-MDA ............................................................................................................................................................ MDEA ................................................................................................................................................................................ MDMA ................................................................................................................................................................................ PMA ................................................................................................................................................................................... 5-MeO-DMT ....................................................................................................................................................................... AMT ................................................................................................................................................................................... Bufotenine .......................................................................................................................................................................... DET .................................................................................................................................................................................... DMT ................................................................................................................................................................................... Psilocybin ........................................................................................................................................................................... Psilocin .............................................................................................................................................................................. 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................... 4-Methyl-alpha-pyrrolidinohexiophenone ........................................................................................................................... PCE ................................................................................................................................................................................... PCPy .................................................................................................................................................................................. TCP .................................................................................................................................................................................... TCPy .................................................................................................................................................................................. JB323 ................................................................................................................................................................................. JB336 ................................................................................................................................................................................. BZP .................................................................................................................................................................................... 4-MePPP ........................................................................................................................................................................... 2C-D .................................................................................................................................................................................. 2C-E ................................................................................................................................................................................... 2C-H .................................................................................................................................................................................. 2C-I .................................................................................................................................................................................... 2C-C .................................................................................................................................................................................. 2C-N .................................................................................................................................................................................. 2C-P ................................................................................................................................................................................... 2C-T-4 ................................................................................................................................................................................ VerDate Sep<11>2014 16:44 Feb 24, 2022 Jkt 256001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\25FEN1.SGM 25FEN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1585 1590 2010 2565 2572 6250 7035 7118 7173 7200 7203 7245 7246 7249 7260 7297 7298 7315 7348 7370 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7446 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 10822 Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices lotter on DSK11XQN23PROD with NOTICES1 Controlled substance Drug code MDPV ................................................................................................................................................................................ 25B-NBOME ...................................................................................................................................................................... 25C-NBOME ...................................................................................................................................................................... 25I-NBOME ....................................................................................................................................................................... Methylone .......................................................................................................................................................................... Butylone ............................................................................................................................................................................. Pentylone ........................................................................................................................................................................... N-Ethylpentyloe ................................................................................................................................................................. Alpha-Pyrrolidinohexanophenone ...................................................................................................................................... Alpha-PVP ......................................................................................................................................................................... Alpha-PBP ......................................................................................................................................................................... Ethylone ............................................................................................................................................................................. AM-694 .............................................................................................................................................................................. Etorphine ........................................................................................................................................................................... Heroin ................................................................................................................................................................................ Normorphine ...................................................................................................................................................................... Acetorphine ........................................................................................................................................................................ U-47700 ............................................................................................................................................................................. AH-7921 ............................................................................................................................................................................. MT-45 ................................................................................................................................................................................ Acetylmethadol .................................................................................................................................................................. Allylprodine ........................................................................................................................................................................ Alphacetylmethadol ........................................................................................................................................................... Alphameprodine ................................................................................................................................................................. Alphamethadol ................................................................................................................................................................... Benzethidine ...................................................................................................................................................................... Betacetylmethadol ............................................................................................................................................................. Clonitazine ......................................................................................................................................................................... Isontonitazene ................................................................................................................................................................... Diampromide ..................................................................................................................................................................... Diethylthiambutene ............................................................................................................................................................ Dimethylthiambutene ......................................................................................................................................................... Etonitazene ........................................................................................................................................................................ Ketobemidone .................................................................................................................................................................... MPPP ................................................................................................................................................................................. PEPAP ............................................................................................................................................................................... Tilidine ............................................................................................................................................................................... Acryl Fentanyl .................................................................................................................................................................... Para-fluorofentanyl ............................................................................................................................................................ 3-Methylfentanyl ................................................................................................................................................................ Alpha-methylfentanyl ......................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................... Ortho-fluorofentanyl ........................................................................................................................................................... Acetylfentanyl .................................................................................................................................................................... Butyrylfentanyl ................................................................................................................................................................... Para-fluorofentanyl ............................................................................................................................................................ 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ........................................... Methoxyacetyl fentanyl ...................................................................................................................................................... Para-chloroisobutyryl fentanyl ........................................................................................................................................... Isobutyrylfentanyl ............................................................................................................................................................... Beta-Hydroxyfentanyl ........................................................................................................................................................ Beta-Hydroxy-3-methylfentanyl ......................................................................................................................................... Alpha-Methylthiofentanyl ................................................................................................................................................... 3-Methylthiofentanyl ........................................................................................................................................................... Furanylfentanyl .................................................................................................................................................................. Thiofentanyl ....................................................................................................................................................................... Beta-Hydroxythiofentanyl ................................................................................................................................................... Para-Methoxybutyryl Fetnanyl ........................................................................................................................................... Ocfentanil ........................................................................................................................................................................... Valeryl Fentanyl ................................................................................................................................................................. Tetrahydrofuranyl Fentanyl ................................................................................................................................................ Crotonyl Fentanyl .............................................................................................................................................................. Cyclopropyl Fentanyl ......................................................................................................................................................... Cyclopentyl Fentanyl ......................................................................................................................................................... Fentanyl Related Compounds ........................................................................................................................................... Amphetamine ..................................................................................................................................................................... Methamphetamine ............................................................................................................................................................. 1-Phenylcyclohexylamine .................................................................................................................................................. PCP ................................................................................................................................................................................... ANPP ................................................................................................................................................................................. Norfentanyl ........................................................................................................................................................................ P2P .................................................................................................................................................................................... PCC ................................................................................................................................................................................... Alphaprodine ...................................................................................................................................................................... VerDate Sep<11>2014 16:44 Feb 24, 2022 Jkt 256001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\25FEN1.SGM 25FEN1 7535 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7547 7694 9056 9200 9313 9319 9547 9551 9560 9601 9602 9603 9604 9605 9606 9607 9612 9614 9615 9616 9619 9624 9628 9661 9663 9750 9811 9812 9813 9814 9815 9816 9821 9822 9823 9824 9825 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9840 9843 9844 9845 9847 9850 1100 1105 7460 7471 8333 8366 8501 8603 9010 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II 10823 Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices Controlled substance Drug code Anileridine .......................................................................................................................................................................... Cocaine .............................................................................................................................................................................. Diphenoxylate .................................................................................................................................................................... Ecgonine ............................................................................................................................................................................ Levorphanol ....................................................................................................................................................................... Meperidine ......................................................................................................................................................................... Meperidine Intermediate-A ................................................................................................................................................ Meperidine Intermediate-B ................................................................................................................................................ Meperidine Intermediate-C ................................................................................................................................................ Dextropropoxyphene ......................................................................................................................................................... Morphine ............................................................................................................................................................................ Levo-alphacetylmethadol ................................................................................................................................................... Alfentanil ............................................................................................................................................................................ Remifentanil ....................................................................................................................................................................... Sufentanil ........................................................................................................................................................................... Carfentanil ......................................................................................................................................................................... Tapentadol ......................................................................................................................................................................... Fentanyl ............................................................................................................................................................................. The company plans to bulk manufacture the listed controlled substances as analytical materials, proficiency test materials, and academic research materials for distribution to its customers. No other activities for these drug codes are authorized for this registration. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–04057 Filed 2–24–22; 8:45 am] BILLING CODE P In accordance with 21 CFR 1301.34(a), this is notice that on January 13, 2022, Lyndra Therapeutics, 65 Grove Street, Suite 301, Watertown, Massachusetts 02472, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–965] Importer of Controlled Substances Application: Lyndra Therapeutics lotter on DSK11XQN23PROD with NOTICES1 Methadone .................... Lyndra Therapeutics has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 28, 2022. Such persons may also file a written request for a hearing on the application on or before March 28, 2022. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must SUMMARY: 16:44 Feb 24, 2022 Jkt 256001 Drug code Controlled substance Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: VerDate Sep<11>2014 be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. I 9250 Schedule I II The company plans to develop the formulation and process, and then manufacture the finished oral dosage form for use in preclinical and human clinical trials and analysis. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–04061 Filed 2–24–22; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 9020 9041 9170 9180 9220 9230 9232 9233 9234 9273 9300 9648 9737 9739 9740 9743 9780 9801 Schedule II II II II II II II II II II II II II II II II II II DEPARTMENT OF LABOR Agency Information Collection Activities; Submission for OMB Review; Comment Request; Miner’s Claim for Benefits and Employment History Notice of availability; request for comments. ACTION: The Department of Labor (DOL) is submitting this Office of Workers’ Compensation Programs (OWCP)-sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that the agency receives on or before March 28, 2022. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Comments are invited on: (1) Whether the collection of information is necessary for the proper performance of the functions of the Department, including whether the information will have practical utility; (2) if the information will be processed and used in a timely manner; (3) the accuracy of the agency’s estimates of the burden and cost of the collection of information, including the validity of the methodology and assumptions used; (4) ways to enhance the quality, utility and clarity of the information collection; and SUMMARY: E:\FR\FM\25FEN1.SGM 25FEN1

Agencies

[Federal Register Volume 87, Number 38 (Friday, February 25, 2022)]
[Notices]
[Pages 10820-10823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04057]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-964]


Bulk Manufacturer of Controlled Substances Application: Synthcon 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Synthcon LLC has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before April 26, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 2, 2021,

[[Page 10821]]

Synthcon LLC, 770 Wooten Road, Suite 101, Colorado Springs, Colorado 
80915-3538, applied to be registered as a bulk manufacturer of the 
following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
           Controlled substance               Drug code      Schedule
------------------------------------------------------------------------
3-FMC.....................................          1233  I
Cathinone.................................          1235  I
Methcathinone.............................          1237  I
4-FMC.....................................          1238  I
Pentedrone................................          1246  I
Mephedrone(4-Methyl-N-methylcathinone)....          1248  I
4-MEC.....................................          1249  I
Naphyrone.................................          1258  I
N-Ethylamphetamine........................          1475  I
N,N-Dimethylamphetamine...................          1480  I
Aminorex..................................          1585  I
Cis-4-Methylaminorex......................          1590  I
GHB.......................................          2010  I
Methaqualone..............................          2565  I
Mecloqualone..............................          2572  I
JWH-250...................................          6250  I
ADB-PINACA................................          7035  I
JWH-018...................................          7118  I
JWH-073...................................          7173  I
JWH-200...................................          7200  I
JWH-203...................................          7203  I
4-Methyl-alpha-ethylaminopentiophenone....          7245  I
N-Ethyhexedrone...........................          7246  I
AET.......................................          7249  I
Ibogaine..................................          7260  I
CP-47,497.................................          7297  I
CP-47,497 C8 HOMOLOG......................          7298  I
LSD.......................................          7315  I
2C-T-7....................................          7348  I
Tetrahydrocannabinols.....................          7370  I
Mescaline.................................          7381  I
2C-T-2....................................          7385  I
3,4,5-TMA.................................          7390  I
DOB.......................................          7391  I
2CB.......................................          7392  I
DOM.......................................          7395  I
2,5-DMA...................................          7396  I
JWH-398...................................          7398  I
DOE.......................................          7399  I
MDA.......................................          7400  I
5-METHOXY-MDA.............................          7401  I
N-HYDROXY-MDA.............................          7402  I
MDEA......................................          7404  I
MDMA......................................          7405  I
PMA.......................................          7411  I
5-MeO-DMT.................................          7431  I
AMT.......................................          7432  I
Bufotenine................................          7433  I
DET.......................................          7434  I
DMT.......................................          7435  I
Psilocybin................................          7437  I
Psilocin..................................          7438  I
5-Methoxy-N,N-diisopropyltryptamine.......          7439  I
4-Methyl-alpha-pyrrolidinohexiophenone....          7446  I
PCE.......................................          7455  I
PCPy......................................          7458  I
TCP.......................................          7470  I
TCPy......................................          7473  I
JB323.....................................          7482  I
JB336.....................................          7484  I
BZP.......................................          7493  I
4-MePPP...................................          7498  I
2C-D......................................          7508  I
2C-E......................................          7509  I
2C-H......................................          7517  I
2C-I......................................          7518  I
2C-C......................................          7519  I
2C-N......................................          7521  I
2C-P......................................          7524  I
2C-T-4....................................          7532  I

[[Page 10822]]

 
MDPV......................................          7535  I
25B-NBOME.................................          7536  I
25C-NBOME.................................          7537  I
25I-NBOME.................................          7538  I
Methylone.................................          7540  I
Butylone..................................          7541  I
Pentylone.................................          7542  I
N-Ethylpentyloe...........................          7543  I
Alpha-Pyrrolidinohexanophenone............          7544  I
Alpha-PVP.................................          7545  I
Alpha-PBP.................................          7546  I
Ethylone..................................          7547  I
AM-694....................................          7694  I
Etorphine.................................          9056  I
Heroin....................................          9200  I
Normorphine...............................          9313  I
Acetorphine...............................          9319  I
U-47700...................................          9547  I
AH-7921...................................          9551  I
MT-45.....................................          9560  I
Acetylmethadol............................          9601  I
Allylprodine..............................          9602  I
Alphacetylmethadol........................          9603  I
Alphameprodine............................          9604  I
Alphamethadol.............................          9605  I
Benzethidine..............................          9606  I
Betacetylmethadol.........................          9607  I
Clonitazine...............................          9612  I
Isontonitazene............................          9614  I
Diampromide...............................          9615  I
Diethylthiambutene........................          9616  I
Dimethylthiambutene.......................          9619  I
Etonitazene...............................          9624  I
Ketobemidone..............................          9628  I
MPPP......................................          9661  I
PEPAP.....................................          9663  I
Tilidine..................................          9750  I
Acryl Fentanyl............................          9811  I
Para-fluorofentanyl.......................          9812  I
3-Methylfentanyl..........................          9813  I
Alpha-methylfentanyl......................          9814  I
Acetyl-alpha-methylfentanyl...............          9815  I
Ortho-fluorofentanyl......................          9816  I
Acetylfentanyl............................          9821  I
Butyrylfentanyl...........................          9822  I
Para-fluorofentanyl.......................          9823  I
4-Fluoroisobutyryl fentanyl (N-(4-                  9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-4-
 yl)isobutyramide).
Methoxyacetyl fentanyl....................          9825  I
Para-chloroisobutyryl fentanyl............          9826  I
Isobutyrylfentanyl........................          9827  I
Beta-Hydroxyfentanyl......................          9830  I
Beta-Hydroxy-3-methylfentanyl.............          9831  I
Alpha-Methylthiofentanyl..................          9832  I
3-Methylthiofentanyl......................          9833  I
Furanylfentanyl...........................          9834  I
Thiofentanyl..............................          9835  I
Beta-Hydroxythiofentanyl..................          9836  I
Para-Methoxybutyryl Fetnanyl..............          9837  I
Ocfentanil................................          9838  I
Valeryl Fentanyl..........................          9840  I
Tetrahydrofuranyl Fentanyl................          9843  I
Crotonyl Fentanyl.........................          9844  I
Cyclopropyl Fentanyl......................          9845  I
Cyclopentyl Fentanyl......................          9847  I
Fentanyl Related Compounds................          9850  I
Amphetamine...............................          1100  II
Methamphetamine...........................          1105  II
1-Phenylcyclohexylamine...................          7460  II
PCP.......................................          7471  II
ANPP......................................          8333  II
Norfentanyl...............................          8366  II
P2P.......................................          8501  II
PCC.......................................          8603  II
Alphaprodine..............................          9010  II

[[Page 10823]]

 
Anileridine...............................          9020  II
Cocaine...................................          9041  II
Diphenoxylate.............................          9170  II
Ecgonine..................................          9180  II
Levorphanol...............................          9220  II
Meperidine................................          9230  II
Meperidine Intermediate-A.................          9232  II
Meperidine Intermediate-B.................          9233  II
Meperidine Intermediate-C.................          9234  II
Dextropropoxyphene........................          9273  II
Morphine..................................          9300  II
Levo-alphacetylmethadol...................          9648  II
Alfentanil................................          9737  II
Remifentanil..............................          9739  II
Sufentanil................................          9740  II
Carfentanil...............................          9743  II
Tapentadol................................          9780  II
Fentanyl..................................          9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances as analytical materials, proficiency test materials, and 
academic research materials for distribution to its customers. No other 
activities for these drug codes are authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-04057 Filed 2-24-22; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.